December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
High & Low Molecular Weight Hyaluronan Differentially Modulate Adenoviral-Mediated Transgene Expression
Author Affiliations & Notes
  • MY Hurwitz
    Pediatrics Hematology Oncology Baylor College Of Medicine Houston TX
  • SR Chaudhuri
    Baylor College of Medicine Houston TX
    Texas Children's Cancer Center
  • V Holcombe
    Baylor College of Medicine Houston TX
  • J-R Lin
    Baylor College of Medicine Houston TX
  • RL Hurwitz
    Cell and Gene Therapy
    Baylor College of Medicine Houston TX
  • Footnotes
    Commercial Relationships   M.Y. Hurwitz, None; S.R. Chaudhuri, None; V. Holcombe, None; J. Lin, None; R.L. Hurwitz, None. Grant Identification: Foundation for Research
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4620. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      MY Hurwitz, SR Chaudhuri, V Holcombe, J-R Lin, RL Hurwitz; High & Low Molecular Weight Hyaluronan Differentially Modulate Adenoviral-Mediated Transgene Expression . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4620.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose:To determine the effect and mechanism of hyaluronan modulation of adenoviral transgene expression Methods:Cells were transduced using adenoviral vectors containing expression constructs for firefly luciferase in the presence or absence hyaluronan. The time-dependence of enhancement was established by varying the time that the cells were incubated with hyaluronan after adenoviral exposure. The effect of digesting the hyaluronan with lyase was determined. Results:The enhancement of transgene expression by high molecular weight (MW) hyaluronan was time-dependent and indicated a critical time period of 4-6 hours after adenoviral exposure. High MW hyaluronan was found to enhance adenoviral transgene expression by 1-2 orders of magnitude. Lyase digestion of the hyaluronan not only abrogated the enhancement but actually blocked adenoviral transgene expression. Hyaluronan had no effect on adenoviral-mediated transgene expression in Jurkat cells, a human cell line that contains the adenoviral receptor CAR but not αvß5, an integrin that mediates adenoviral internalization, or CD44, a hyaluronan receptor. When a stable Jurkat cell line expressing CD44 was produced, hyaluronan was found to enhance transgene expression. An antibody that specifically blocks hyaluronan binding to CD44 inhibited transgene expression in murine EpH4 cells that express CD44. Conclusion:Hyaluronan, a macropolysaccharide, is a major component of vitreous and enhances adenoviral-mediated transgene expression through an interaction with its receptor, CD44. The time-dependence of enhanced transgene expression suggests that hyaluronan must be present after adenoviral internalization but prior to transcription of viral DNA. The molecular weight of the polysaccharide is critical; high molecular weight hyaluronan enhances and low molecular weight hyaluronan inhibits adenoviral transgene expression. These results may have implications not only for enhancing gene therapy applications using adenoviral vectors but also for inhibiting adenovirus infections.

Keywords: 419 gene transfer/gene therapy • 307 adenovirus • 629 vitreous 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.